Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 238197, 10 pages
http://dx.doi.org/10.1155/2014/238197
Research Article

The Serum Glycome to Discriminate between Early-Stage Epithelial Ovarian Cancer and Benign Ovarian Diseases

1Institute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité Medical University, Augustenburger Platz 1, 13353 Berlin, Germany
2Department of Gynecology, Charité Medical University, Augustenburger Platz 1, 13353 Berlin, Germany

Received 3 April 2014; Accepted 11 July 2014; Published 12 August 2014

Academic Editor: Natacha Turck

Copyright © 2014 Karina Biskup et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Supplementary Data Table 1: N-glycan structures identified by MALDI-TOF-MS Average areas were calculated for each glycan mass for healthy controls, benign ovarian disease and EOC-patients.

  1. Supplementary Material